Chemoinformaics analysis of 3,5,5-Trimethyl-4-(3-oxobutyl)cyclohex-2-en-1-one
Molecular Weight | 208.301 | nRot | 3 |
Heavy Atom Molecular Weight | 188.141 | nRig | 8 |
Exact Molecular Weight | 208.146 | nRing | 1 |
Solubility: LogS | -2.216 | nHRing | 0 |
Solubility: LogP | 2.023 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 36.6499 |
nHD | 0 | BPOL | 21.8001 |
QED | 0.668 |
Synth | 3.076 |
Natural Product Likeliness | 1.297 |
NR-PPAR-gamma | 0.912 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.528 |
Pgp-sub | 0.132 |
HIA | 0.006 |
CACO-2 | -4.754 |
MDCK | 0.0000215 |
BBB | 0.959 |
PPB | 0.647048 |
VDSS | 1.338 |
FU | 0.257454 |
CYP1A2-inh | 0.046 |
CYP1A2-sub | 0.387 |
CYP2c19-inh | 0.226 |
CYP2c19-sub | 0.793 |
CYP2c9-inh | 0.111 |
CYP2c9-sub | 0.888 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.844 |
CYP3a4-inh | 0.021 |
CYP3a4-sub | 0.234 |
CL | 7.442 |
T12 | 0.853 |
hERG | 0.005 |
Ames | 0.033 |
ROA | 0.03 |
SkinSen | 0.689 |
Carcinogencity | 0.046 |
EI | 0.969 |
Respiratory | 0.681 |
NR-Aromatase | 0.013 |
Antiviral | Yes |
Prediction | 0.649469 |